drugset / Trial / NCT02467400
Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study is designed to answer the question as to whether the sympathetic nervous system is an important determinant of bone metabolism in humans.
Timeline
- Start
- 2015-07-01
- Primary completion
- 2017-10-26
- Completion
- 2018-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atenolol | Other / unclassified | 50 mg | — |
| Comparator | Nebivolol | Other / unclassified | 5 mg | — |
| Comparator | Propranolol | Small molecule | 20 mg | — |
| Comparator | Propranolol | Small molecule | 40 mg | — |